|
|
|
Histology of Normal Breast |
|
|
4 | (10) |
|
|
|
Breast Life Cycle Changes |
|
|
14 | (8) |
|
|
|
SECTION 2 BREAST SPECIMENS, PROCESSIONG |
|
|
|
Breast Specimens: General Considerations |
|
|
22 | (6) |
|
|
|
|
28 | (12) |
|
|
|
|
40 | (6) |
|
|
|
|
46 | (6) |
|
|
|
|
52 | (6) |
|
|
|
|
58 | (4) |
|
|
|
Intraoperative Consultation |
|
|
62 | (12) |
|
|
|
|
SECTION 3 DIAGNOSTIC PATTERNS |
|
|
|
Overview of Papillary Lesions |
|
|
74 | (10) |
|
|
|
Overview of Spindle Cell Lesions |
|
|
84 | (8) |
|
|
|
Overview of Small Acinar Proliferations |
|
|
92 | (10) |
|
|
|
Overview of Epithelial/Myoepithelial Lesions |
|
|
102 | (10) |
|
|
|
SECTION 4 DISORDERS OF DEVELOPMENT |
|
|
|
|
112 | (2) |
|
|
|
Gynecomastia in Men and Gynecomastia-Like Changes in Women |
|
|
114 | (4) |
|
|
|
Hamartoma (Fibroadenolipoma) |
|
|
118 | (6) |
|
|
|
SECTION 5 BENING EPITHELIAL LESIONS |
|
|
|
Epidemiology: Lesions Conferring Increased Risk of Breast Carcinoma |
|
|
124 | (6) |
|
|
|
|
130 | (4) |
|
|
|
Columnar Cell Change, Columnar Cell Hyperplasia, and Flat Epithelial Atypia |
|
|
134 | (6) |
|
|
|
|
140 | (4) |
|
|
|
|
144 | (4) |
|
|
|
Syringomatous Tumor of the Nipple |
|
|
148 | (6) |
|
|
|
|
154 | (8) |
|
|
|
|
162 | (4) |
|
|
|
Radial Sclerosing Lesion/Radial Scar |
|
|
166 | (6) |
|
|
|
Papilloma, Large Duct and Small Duct |
|
|
172 | (8) |
|
|
|
|
180 | (6) |
|
|
|
|
186 | (8) |
|
|
|
Atypical Ductal Hyperplasia |
|
|
194 | (8) |
|
|
|
Atypical Lobular Hyperplasia |
|
|
202 | (6) |
|
|
|
|
208 | (10) |
|
|
|
|
|
Risk Factors for Developing Breast Carcinoma |
|
|
218 | (6) |
|
|
|
|
|
Lobular Carcinoma In Situ |
|
|
224 | (10) |
|
|
|
|
234 | (14) |
|
|
|
Ductal Carcinoma In Situ, Paget Disease |
|
|
248 | (10) |
|
|
|
|
258 | (6) |
|
|
|
Encapsulated Papillary Carcinoma |
|
|
264 | (6) |
|
|
|
Solid Papillary Carcinoma |
|
|
270 | (6) |
|
|
|
TYPES OF INVASIVE CARCINOMA |
|
|
|
Invasive Breast Carcinoma of No Special Type (Ductal) |
|
|
276 | (8) |
|
|
|
Invasive Lobular Carcinoma |
|
|
284 | (12) |
|
|
|
Tubular/Cribriform Carcinoma |
|
|
296 | (8) |
|
|
|
Mucinous (Colloid) Carcinoma |
|
|
304 | (10) |
|
|
|
Invasive Papillary Carcinoma |
|
|
314 | (2) |
|
|
|
Invasive Micropapillary Carcinoma |
|
|
316 | (8) |
|
|
|
|
324 | (10) |
|
|
|
Low-Crade Adenosquamous Carcinoma |
|
|
334 | (8) |
|
|
|
Triple Negative and Basal-Like Carcinomas |
|
|
342 | (8) |
|
|
|
|
350 | (12) |
|
|
|
|
362 | (6) |
|
|
|
|
368 | (8) |
|
|
|
|
376 | (6) |
|
|
|
Invasive Apocrine Carcinoma |
|
|
382 | (6) |
|
|
|
Invasive Neuroendocrine Carcinoma |
|
|
388 | (8) |
|
|
|
Invasive Carcinoma With Osteoclast-Like Giant Cells |
|
|
396 | (2) |
|
|
|
Carcinoma With Extensive Intraductal Component |
|
|
398 | (6) |
|
|
|
SECTION 7 PROGNOSTIC AND PREDICTIVE FACTORS |
|
|
|
Introduction: Prognostic and Predictive Factors |
|
|
404 | (6) |
|
|
|
AJCC Breast Cancer Staging |
|
|
410 | (8) |
|
|
|
Locally Advanced Breast Cancer |
|
|
418 | (4) |
|
|
|
|
|
Locally Recurrent Carcinoma |
|
|
422 | (6) |
|
|
|
|
428 | (10) |
|
|
|
|
438 | (6) |
|
|
|
|
444 | (12) |
|
|
|
|
456 | (8) |
|
|
|
|
464 | (4) |
|
|
|
|
|
Hormone Receptors (ER/PR) |
|
|
468 | (10) |
|
|
|
|
478 | (14) |
|
|
|
|
492 | (4) |
|
|
|
Circulating Tumor Cells and Circulating Tumor DNA |
|
|
496 | (4) |
|
|
|
|
500 | (4) |
|
|
|
Expression Profiling, mRNA |
|
|
504 | (6) |
|
|
|
Expression Profiling, Oncotype DX Assay |
|
|
510 | (4) |
|
|
|
Expression Profiling, MammaPrint Assay |
|
|
514 | (2) |
|
|
|
Expression Profiling, Prosigna (NanoString)/PAM50 |
|
|
516 | (2) |
|
|
|
Expression Profiling, Protein |
|
|
518 | (8) |
|
|
|
Expression Profiling, EndoPredict |
|
|
526 | (4) |
|
|
|
SECTION 8 STROMAL LESIONS |
|
|
|
|
530 | (8) |
|
|
|
|
538 | (10) |
|
|
|
Pseudoangiomatous Stromal Hyperplasia |
|
|
548 | (4) |
|
|
|
|
552 | (8) |
|
|
|
|
560 | (4) |
|
|
|
Diabetic Mastopathy/Lymphocytic Mastopathy |
|
|
564 | (4) |
|
|
|
|
568 | (6) |
|
|
|
|
574 | (6) |
|
|
|
|
580 | (8) |
|
|
|
|
588 | (6) |
|
|
|
Papillary Endothelial Hyperplasia |
|
|
594 | (2) |
|
|
|
Atypical Vascular Lesions of Skin |
|
|
596 | (4) |
|
|
|
|
600 | (10) |
|
|
|
|
610 | (8) |
|
|
|
SECTION 9 INFLAMMATORY LESIONS |
|
|
|
|
618 | (2) |
|
|
|
|
620 | (8) |
|
|
|
|
628 | (4) |
|
|
|
|
632 | (2) |
|
|
|
Squamous Metaplasia of Lactiferous Ducts |
|
|
634 | (6) |
|
|
|
|
640 | (8) |
|
|
|
|
648 | (2) |
|
|
|
|
650 | (2) |
|
|
|
|
652 | (2) |
|
|
|
IgC4-Related Sclerosing Mastitis |
|
|
654 | (6) |
|
|
|
SECTION 10 OTHER TYPES OF MALIGNANCIES |
|
|
|
|
660 | (6) |
|
|
|
|
666 | (12) |
|
|
|
SECTION 11 HEREDITARY BREAST DISEASE |
|
|
|
|
678 | (8) |
|
|
|
Germline Mutations Conferring Increased Risk of |
|
|
686 | (2) |
|
Breast Cancer: Tables David G. Hicks |
|
|
|
Breast/Ovarian Cancer Syndrome: BRCA1 |
|
|
688 | (6) |
|
|
|
Breast/Ovarian Cancer Syndrome: BRCA2 |
|
|
694 | (4) |
|
|
|
|
698 | (8) |
|
|
|
SECTION 12 UNUSUAL PRESENTATIONS OF BREAST LESIONS |
|
|
|
|
706 | (4) |
|
|
|
|
710 | |
|
|